.
The NGO had drawn court’s attention to a publication on offering Hydroxychloroquine, Azithromycin to clients with heart conditions.
The Supreme Court on Thursday asked an NGO to approach the Indian Council of Medical Research (ICMR) with its appointments about seriously ill COVID-19 clients in intensive care units going through “questionable, unverified, non-specific and possibly toxic off-label” usage of anti-malarial drug Hydroxychloroquine and broad-spectrum antibiotic Azithromycin.
A Bench led by Justice N.V. Ramana stopped short of intervening on a writ petition submitted by NGO Individuals for Better Treatment, saying the court is not an expert. It asked Dr. Kunal Saha, president of the NGO, to send his research with ICMR.
Likewise checked out: Remdesivir drug reveals ‘precise’ impact in treatin